Denglong L. Wu

389 Xincun Road
Xincun, 200065, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Correction: Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.

Correction: Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.

Journal: Molecular and cellular biochemistry

Published: July 21, 2026

Tumor Prostate-Specific Antigen Density Can Predict Tumor Aggressiveness and Heterogeneity in Prostate Cancer.

Tumor Prostate-Specific Antigen Density Can Predict Tumor Aggressiveness and Heterogeneity in Prostate Cancer.

Journal: The Prostate

Published: September 08, 2025

Protective Role of the EGR1-Nudt16L1 Pathway in Spermatogonial Stem Cells Against Testicular Ischemia-Reperfusion Injury.

Protective Role of the EGR1-Nudt16L1 Pathway in Spermatogonial Stem Cells Against Testicular Ischemia-Reperfusion Injury.

Journal: Cell biology international

Published: September 02, 2025

Restraining SRD5A1 combined with BRD4 inhibitor delaying prostate cancer progression by decreasing AR expression.

Restraining SRD5A1 combined with BRD4 inhibitor delaying prostate cancer progression by decreasing AR expression.

Journal: International journal of biological macromolecules

Published: May 16, 2025

Granulin+ Macrophages Promote Lineage Plasticity in Prostate Cancer Through Paracrine Signaling Loops.

Granulin+ Macrophages Promote Lineage Plasticity in Prostate Cancer Through Paracrine Signaling Loops.

Journal: Genomics, proteomics & bioinformatics

Published: September 25, 2024

TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression.

TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression.

Journal: Cancer research

Published: September 20, 2024

Extrachromosomal circular DNA-related SPOCK1 contributes to development and enzalutamide resistance of prostate cancer by regulating epithelial mesenchymal transition.

Extrachromosomal circular DNA-related SPOCK1 contributes to development and enzalutamide resistance of prostate cancer by regulating epithelial mesenchymal transition.

Journal: Heliyon

Published: January 30, 2024

PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression.

PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression.

Journal: The Journal of clinical investigation

Published: August 22, 2023

CYP19A1 is downregulated by BRD4 and suppresses castration-resistant prostate cancer cell invasion and proliferation by decreasing AR expression.

CYP19A1 is downregulated by BRD4 and suppresses castration-resistant prostate cancer cell invasion and proliferation by decreasing AR expression.

Journal: American journal of cancer research

Published: May 05, 2023

Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.

Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.

Journal: The Journal of clinical investigation

Published: April 26, 2023

Study on clinical outcomes between non-transecting urethroplasty and lingual mucosal urethroplasty for iatrogenic bulbar urethral stricture treatment.

Study on clinical outcomes between non-transecting urethroplasty and lingual mucosal urethroplasty for iatrogenic bulbar urethral stricture treatment.

Journal: Basic and clinical andrology

Published: September 29, 2022

Identification of cuproptosis-related genes for predicting the development of prostate cancer.

Identification of cuproptosis-related genes for predicting the development of prostate cancer.

Journal: Open medicine (Warsaw, Poland)

Published: September 26, 2022

Showing 1-12 of 63

Last Updated: 09/26/2026